Mike Alvarez
CEO
Glooko
Glooko offers a cloud‑based diabetes management platform that automatically aggregates and normalizes data from more than 200 glucose meters, CGMs, insulin pumps and wellness devices into a secure, HIPAA‑compliant repository. The solution integrates with EHR systems via FHIR APIs, providing clinicians with real‑time visualizations, machine‑learning risk scores and population‑health dashboards, while a mobile app gives patients unified tracking, reminders and alerts.
Updated 5 months ago
Funding
Raised to date
$100MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Diabetes care is hampered by fragmented data from a wide array of glucose meters, CGMs, insulin pumps, and wellness devices, requiring manual entry and complex integration into electronic health records. This fragmentation leads to inefficient clinical workflows, limited real‑time insights, and suboptimal patient outcomes.
Solution
Glooko delivers a cloud‑based diabetes management platform that automatically aggregates data from more than 200 compatible devices into a single, secure repository. The platform normalizes and visualizes glucose, insulin, diet, and activity data, enabling clinicians to monitor patients remotely and intervene between visits. Integrated APIs and FHIR‑compatible connectors embed the data directly into EHR workflows, reducing manual effort and supporting population‑health analytics. Built‑in machine‑learning models generate risk scores and trend alerts, helping care teams prioritize actions. A mobile app gives patients a unified view of their metrics, food‑tracking tools, and reminders, fostering self‑management. The solution meets HIPAA, GDPR, ISO 13485, and 21 CFR Part 11 compliance, ensuring data security across all user groups.
Target Audience
Primary customers are healthcare providers and health‑system administrators who manage diabetes populations, as well as individuals with diabetes who use connected monitoring devices.
Features
- Compatibility with >200 diabetes and health‑monitoring devices, including Abbott FreeStyle Libre CGMs, Dexcom G6/G7, insulin pumps, smart pens, and fitness wearables.
- Automatic data ingestion via Bluetooth, USB, or cloud sync, eliminating manual entry and ensuring near‑real‑time updates.
- Cloud‑hosted analytics engine that normalizes data, visualizes trends, and applies machine‑learning algorithms for hypoglycemia risk prediction and time‑in‑range scoring.
- Seamless EHR integration through FHIR‑based APIs and Epic/Allscripts connectors, allowing clinicians to view data within existing workflows.
- Population‑health dashboard for health systems, offering cohort analytics, protocol adherence tracking, and outcome reporting.
- Secure, role‑based access with end‑to‑end encryption, supporting HIPAA, GDPR, ISO 13485, and 21 CFR Part 11 certifications.
- Mobile app features include food logging, medication reminders, and customizable alerts to improve patient engagement.
- Developer API for life‑science partners to access de‑identified real‑world data for clinical trials and research.